Targeting Nucleotide Metabolism for Enhancing Antitumor Immunity

  • 9,607

    Total Downloads

  • 44k

    Total Views and Downloads

About this Research Topic

Submission closed

Background

Over the last decade, targeting the immune system with immunotherapy has revolutionized cancer therapy. Tumors have immunogenicity features similar to those of other pathogenic agents while also reserving many specific biological reactions. Modulation of the existing patient immune system through immune checkpoint inhibitors (ICIs) such as anti-CTLA4, anti-PD1 and anti-PDL1 has resulted in durable remissions across different cancer types. Furthermore, infusion of expanded autologous tumor-specific T cells or chimeric antigen receptor T cells has proven effective in patients with leukemia. Nevertheless, this enthusiasm in the field is somewhat tempered by both the relatively low percentage (<15%) of patients who show an effective antitumor immune response and the inability to accurately identify them, suggesting there are additional mechanisms that are important in driving antitumor immunity. This limited efficacy underscores the importance of better understanding the mechanisms underlying the antitumor immune response, and the mechanisms that mediate response to ICIs, as well as identifying additional pathways to modulate it.

Targeting nucleotide metabolism can not only suppress the occurrence and development of tumors, but also exert serious side effects. The understanding of nucleotide metabolism in tumors, along with in-depth research of nucleotide metabolism, has revealed their non-proliferative roles in immune evasion, revealing the potential effectiveness of nucleotide antimetabolites to enhance immunotherapy. Accumulated evidence suggests that targeting nucleotide metabolism can enhance the antitumor immunity by activating host immune system by maintaining the concentrations of several important metabolites (adenosine and ATP, etc.), facilitating immunogenicity induced by increased mutability and genomic instability via disrupting the purine and pyrimidine pool, and releasing nucleoside analogs via microbes to modulate immunity. Therapeutic approaches targeting nucleotide metabolism combined with immunotherapy have achieved exciting success in preclinical studies. However, due to their lack of specificity for tumor cell nucleotide metabolism, current treatment also inhibits the metabolic processes of normal cells, resulting in serious side effects. Therefore, more in-depth research of the regulatory processes of nucleotide metabolism has key theoretical and clinical significance in cancer immunotherapy.

The submissions may refer to the following areas/topics, these are however examples and submissions are not limited to those:

1. Roles and mechanisms of nucleotides in the activation or suppression of innate and adaptive immune responses.
2. Agents targeting nucleotide receptors combined with immunotherapy for cancer treatment.
3. Pyrimidine or purine metabolism dysregulation in gene mutation and tumor immunogenicity.
4. Microbes that can release nucleoside analogs in regulating the immune microenvironment.
5. Nucleotide metabolism in modulating the cancer-immune cycle.
6. Antimetabolites targeting nucleotide metabolism in combination with immunotherapy agents in preclinical and clinical trial studies.
7. Cytotoxic chemotherapy or specific enzyme inhibitors targeting nucleotide metabolism in improving antitumor immune response.
8. Targeting nucleotide metabolism pathways in cancer immunotherapy, such as targeting purine and pyrimidine pathways, blocking DNA synthesis, suppressing the adenosine pathway, and fecal microbiota transplantation.
9. Using computational methods to identify robust genetic and epigenetic biomarkers, gene models, etc. to predict prognosis and antitumor immune response based on multi-omic data.

*NOTE: Manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation are considered out of the scope of this Research Topic.

Keywords: nucleotide metabolism, immunotherapy, antitumor immune response, tumor immunogenicity, immune microenvironment

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Participating Journals

Impact

  • 44kTopic views
  • 13kArticle views
  • 9,607Article downloads
View impact